title: An analysis of the effect of routine medications on hemodialysis vascular access survival.
authors.forename: C J
authors.initials: CJ
authors.lastname: Diskin
authors.forename: T J
authors.initials: TJ
authors.lastname: Stokes
authors.forename: S G
authors.initials: SG
authors.lastname: Thomas
authors.forename: W
authors.initials: W
authors.lastname: Ravis
authors.forename: S
authors.initials: S
authors.lastname: Lock
authors.forename: J
authors.initials: J
authors.lastname: Thomas
authors.forename: L W
authors.initials: LW
authors.lastname: Panus
authors.forename: L
authors.initials: L
authors.lastname: Dansby
authors.forename: T
authors.initials: T
authors.lastname: Carter
mesh_terms: D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D010431:Pentoxifylline / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D016016:Proportional Hazards Models; D006435:Renal Dialysis / Q000379:methods*; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D010726:Phosphodiesterase Inhibitors; D010431:Pentoxifylline